(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

VITADHA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

VITADHA

ST13

US500000079211067

Classe

5

Pedido

79211067

Registro

5510355

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

54

Atualização mais recente

29/06/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5

Data de depósito

08/03/2017

Data de registro

10/07/2018

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

20/03/2025

Última transação

29/06/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

PROVINS, IT

Examinador

BLANE, SUZANNE

Localização atual

Historical data usage

Titulares e representantes

Titulares

U.G.A. NUTRACEUTICALS SRL
U.G.A. NUTRACEUTICALS SRL

Representantes

Leo M. Loughlin Rothwell, Figg, Ernst & Manbeck, PC

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceuticals and medical preparations for treating joint diseasemetabolic disordersto help regulate blood pressure; veterinary preparations for treating joint diseasemetabolic disordersto help regulate blood pressure; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary usefood for babies; dietary supplements for humans and animals; medical plasters being materials for dressings; material for stopping teethdental wax; disinfectants; preparations for destroying vermin; fungicidesherbicides; nutritional supplements; albumin dietary supplements; alginate dietary supplements; casein dietary supplements; dietary supplements for animals; enzyme dietary supplements; flaxseed dietary supplements; flaxseed oil dietary supplements; glucose dietary supplements; lecithin dietary supplements; linseed dietary supplements; linseed oil dietary supplements; mineral food supplements; pollen dietary supplements; propolis dietary supplements; protein dietary supplements; protein supplements for animals; royal jelly dietary supplements; wheat germ dietary supplements; yeast dietary supplements; dietary fiber for treating constipation; dietary fibre to aid digestion; food for babies; dietetic foods adapted for medical purposes; dietetic beverages adapted for medical purposes; starch for dietetic or pharmaceutical purposes; by-products of the processing of cereals for dietetic or medical purposes; dietetic foods adapted for medical use; infant formula; powdered milk for babies; candymedicated; dressingsmedical; amino acids for medical purposes; chewing gum for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for medical purposes; chewing gum for medical purposes; pearl powder for medical purposes; pomades for medical purposes; malted milk beverages for medical purposes; pharmaceutical preparations for treating joint diseasemetabolic disordersto help regulate blood pressure; veterinary preparations for treating joint diseasemetabolic disordersto help regulate blood pressure; vitamin preparations; preparations of trace elements for human and animal useDHAvitamin D3 and l-methylfolate; all of the foregoing containing DHA

Publicações

Histórico de despachos e eventos da marca no USPTO.

54 publicações encontradas

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

29/06/2026

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

05/03/2026

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

22/12/2025

XXCR

GENERIC MADRID TRANSACTION CREATED

22/12/2025

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

20/11/2025

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

06/07/2025

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

20/03/2025

71AG

REGISTERED-SEC.71 ACCEPTED

20/03/2025

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

13/12/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/12/2024

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

06/12/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/12/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/12/2024

PR71

POST REGISTRATION ACTION MAILED - SEC.71

25/11/2024

PR71

POST REGISTRATION ACTION MAILED - SEC.71

06/11/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/10/2024

ES71

TEAS SECTION 71 RECEIVED

22/02/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

10/07/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

11/06/2021

CORV

REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED

19/06/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

22/05/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

22/05/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

22/05/2020

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

22/05/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

22/05/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

22/05/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

22/05/2020

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

16/11/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

26/10/2018

FIMP

FINAL DISPOSITION PROCESSED

26/10/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/10/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

10/07/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

24/04/2018

PUBO

PUBLISHED FOR OPPOSITION

24/04/2018

GPNX

NOTIFICATION PROCESSED BY IB

20/04/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/04/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/04/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/04/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

20/03/2018

DOCK

ASSIGNED TO EXAMINER

19/01/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

17/01/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

16/01/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

16/01/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

16/01/2018

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

16/01/2018

RFNT

REFUSAL PROCESSED BY IB

04/08/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

15/07/2017

RFRR

REFUSAL PROCESSED BY MPU

15/07/2017

MAFR

APPLICATION FILING RECEIPT MAILED

11/07/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/07/2017

CNRT

NON-FINAL ACTION WRITTEN

07/07/2017

DOCK

ASSIGNED TO EXAMINER

05/07/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/07/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

29/06/2017

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace VITADHA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.